Company Profile
InMode Stock Price, News & Catalysts
- Ticker:
- INMD
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- Israel
Stock performance
15.06 USD (+0.94%)
Close
Last updated: August 21, 2026
855M USD
Market cap
Why the stock is moving
As of Aug 21, 2026, INMD closed up 0.94% at $15.06. No new same-company headline was identified in the current news window.
Company overview
Business overview
InMode is a medical aesthetics company focused on energy-based minimally invasive platforms for body contouring and related procedures.
Geographic Base and Sector Classification
Headquartered in Israel and listed on NASDAQ, InMode sits in aesthetic medtech.
Business Model Characteristics
The company depends on procedure adoption, device sales, and recurring demand from aesthetic providers.
Position Within the Biotechnology Landscape
InMode is outside biotech but belongs to the procedure-driven healthcare-technology segment where product cycles matter.
Future catalysts
- InMode's catalysts are body-contouring demand, women's-health procedures, and international growth in minimally invasive aesthetics. The company tends to move on procedural adoption and channel execution.
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of InMode (INMD)?
InMode (INMD) most recently closed at 15.06 USD, a +0.94% move versus the previous session.
What is the market cap of InMode (INMD)?
InMode currently has a market capitalization of 855M USD on BioPharmSignal.
What does InMode do?
InMode is a medical aesthetics company focused on energy-based minimally invasive platforms for body contouring and related procedures.
On which exchange is INMD stock listed?
InMode (INMD) is associated with NASDAQ, Israel, Biopharma.
What is InMode?
InMode's catalysts are body-contouring demand, women's-health procedures, and international growth in minimally invasive aesthetics.
Which conditions is InMode targeting with InMode?
InMode's catalysts are body-contouring demand, women's-health procedures, and international growth in minimally invasive aesthetics.
How does InMode describe recent progress with InMode?
InMode's catalysts are body-contouring demand, women's-health procedures, and international growth in minimally invasive aesthetics.
What future catalysts are investors watching for InMode?
InMode's catalysts are body-contouring demand, women's-health procedures, and international growth in minimally invasive aesthetics. The company tends to move on procedural adoption and channel execution.